Skip to main content

cariprazine (Reagila®)

 

Status: In progress

Treatment of schizophrenia in adult patients.

Medicine details

Medicine name cariprazine (Reagila®)
Formulation 1.5 mg, 3 mg, 4.5 mg, 6 mg hard capsules
Reference number 5032
Indication

As above

Company Recordati Pharmaceuticals Ltd
BNF chapter Central nervous system
Submission type Resubmission
Status In progress
NMG meeting date TBC
AWMSG meeting date TBC
Date of issue TBC